{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:50:56Z","timestamp":1761918656382},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s10875-004-6240-7","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T05:39:48Z","timestamp":1104212388000},"page":"600-611","source":"Crossref","is-referenced-by-count":30,"title":["Programmed Cell Death of Peripheral Blood B Cells Determined by Laser Scanning Cytometry in Sj\ufffdgren?s Syndrome with a Special Emphasis on BAFF"],"prefix":"10.1007","volume":"24","author":[{"given":"PETER","family":"SZODORAY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STIG","family":"JELLESTAD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PHILIP","family":"ALEX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TONG","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PATRICK C.","family":"WILSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHAEL","family":"CENTOLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHAN G.","family":"BRUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROLAND","family":"JONSSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1736","volume-title":"Arthritis and Allied Conditions: A Textbook of Rheumatology","author":"R Jonsson","year":"2001","unstructured":"Jonsson R, Haga H-J, Gordon T: Sj\u00f6gren?s syndrome. In Arthritis and Allied Conditions: A Textbook of Rheumatology, WJ Koopman (ed), 14th edn. Philadelphia, PA, Lippincott Williams & Wilkins, 2001, pp 1736?1759","edition":"14th edn"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1601-0825.2002.02846.x","volume":"8","author":"R Jonsson","year":"2002","unstructured":"Jonsson R, Moen K, Vestrheim D, Szodoray P: Current issues in Sjogren?s syndrome. Oral Dis8:130?140, 2002","journal-title":"Oral Dis"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","volume":"25","author":"JM Anaya","year":"1996","unstructured":"Anaya JM, McGuff HS, Banks PM, Talal N: Clinicopathological factors relating malignant lymphoma with Sjogren?s syndrome. Semin Arthritis Rheum25:337?346, 1996","journal-title":"Semin Arthritis Rheum"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-3083.2001.00989.x","volume":"54","author":"JO Bohnhorst","year":"2001","unstructured":"Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM: Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjogren?s syndrome. Scand J Immunol54:421?427, 2001","journal-title":"Scand J Immunol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","volume":"167","author":"JO Bohnhorst","year":"2001","unstructured":"Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM: Bm1--Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren?s syndrome. J Immunol167:3610?3618, 2001","journal-title":"J Immunol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/clim.2002.5199","volume":"103","author":"JO Bohnhorst","year":"2002","unstructured":"Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM: Abnormal B cell differentiation in primary Sjogren?s syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration. Clin Immunol103:79?88, 2002","journal-title":"Clin Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.10445","volume":"46","author":"A Hansen","year":"2002","unstructured":"Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, Dorner T: Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren?s syndrome. Arthritis Rheum46:2160?2171, 2002","journal-title":"Arthritis Rheum"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.1999.00778.x","volume":"115","author":"A Halse","year":"1999","unstructured":"Halse A, Harley JB, Kroneld U, Jonsson R: Ro\/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjogren?s syndrome. Clin Exp Immunol 115:203?207, 1999","journal-title":"Clin Exp Immunol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-3083.2002.01058.x","volume":"55","author":"S Salomonsson","year":"2002","unstructured":"Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M: Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren?s syndrome. Scand J Immunol55:336?342, 2002","journal-title":"Scand J Immunol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","volume":"44","author":"N Amft","year":"2001","unstructured":"Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD: Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren?s syndrome. Arthritis Rheum44:2633?2641, 2001","journal-title":"Arthritis Rheum"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.LAB.0000059930.92336.E2","volume":"83","author":"P Szodoray","year":"2003","unstructured":"Szodoray P, Jellestad S, Teague MO, Jonsson R: Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjogren?s syndrome. Lab Invest83:357?365, 2003","journal-title":"Lab Invest"},{"key":"CR12","first-page":"554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH: European Study Group on Classification Criteria for Sjogren?s Syndrome. Classification criteria for Sjogren?s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis61:554?558, 2002","journal-title":"Classification criteria for Sjogren?s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ni0503-410","volume":"4","author":"JT Opferman","year":"2003","unstructured":"Opferman JT, Korsmeyer SJ: Apoptosis in the development and maintenance of the immune system. Nat Immunol4:410?415, 2003","journal-title":"Nat Immunol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","volume":"281","author":"JM Adams","year":"1998","unstructured":"Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science281:1322?1326, 1998","journal-title":"Science"},{"key":"CR15","first-page":"117","volume":"45","author":"J Kusenda","year":"1998","unstructured":"Kusenda J: Bcl-2 family proteins and leukemia. Minireview. Neoplasma45:117?122, 1998","journal-title":"Minireview. Neoplasma"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell74:609?619, 1993","journal-title":"Cell"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-3083.2002.01168.x","volume":"56","author":"M Ohlsson","year":"2002","unstructured":"Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R: CD40, CD154, Bax and Bcl-2 Expression in Sjogren?s Syndrome Salivary Glands: A putative anti-apoptotic role during its effector phases. Scand J Immunol56:561?571, 2002","journal-title":"Scand J Immunol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:24:2:097","volume":"24","author":"GA Bishop","year":"2001","unstructured":"Bishop GA, Hostager BS: Signaling by CD40 and its mimics in B cell activation. Immunol Res24:97?109, 2001","journal-title":"Immunol Res"},{"key":"CR19","first-page":"2345","volume":"156","author":"MR Kehry","year":"1996","unstructured":"Kehry MR: CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. J Immunol156:2345?2348, 1996","journal-title":"Balancing cell survival, growth, and death. J Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","volume":"404","author":"JA Gross","year":"2000","unstructured":"Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature404:995?999, 2000","journal-title":"Nature"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","volume":"285","author":"PA Moore","year":"1999","unstructured":"Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM: BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science285:260?263, 1999","journal-title":"Science"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","volume":"190","author":"F Mackay","year":"1999","unstructured":"Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med190:1697?1710, 1999","journal-title":"J Exp Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0952-7915(02)00332-1","volume":"14","author":"AG Rolink","year":"2002","unstructured":"Rolink AG, Melchers F: BAFFled B cells survive and thrive: Roles of BAFF in B-cell development. Curr Opin Immunol14:266?275, 2002","journal-title":"Curr Opin Immunol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.192.7.953","volume":"192","author":"RK Do","year":"2000","unstructured":"Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S: Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med192:953?964, 2000","journal-title":"J Exp Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.4049\/jimmunol.167.11.6069","volume":"167","author":"IJ Amanna","year":"2001","unstructured":"Amanna IJ, Clise-Dwyer K, Nashold FE, Hoag KA, Hayes CE: Cutting edge: A\/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis. J Immunol167:6069?6072, 2001","journal-title":"J Immunol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL: BAFF: A fundamental survival factor for B cells. Nat Rev Immunol2:465?475, 2002","journal-title":"Nat Rev Immunol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","volume":"109","author":"J Groom","year":"2002","unstructured":"Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F: Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren?s syndrome. J Clin Invest109:59?68, 2002","journal-title":"J Clin Invest"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R: The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren?s syndrome. Ann Rheum Dis62:168?171, 2003","journal-title":"Ann Rheum Dis"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02983377","volume":"78","author":"B Klein","year":"2003","unstructured":"Klein B, Tarte K, Jourdan M, Mathouk K, Moreaux J, Jourdan E, Legouffe E, De Vos J, Rossi JF: Survival and proliferation factors of normal and malignant plasma cells. Int J Hematol78:106?113, 2003","journal-title":"Int J Hematol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s000110050456","volume":"48","author":"JT Cross","year":"1999","unstructured":"Cross JT, Benton HP: The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflamm Res48:255?261, 1999","journal-title":"Inflamm Res"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","volume":"97","author":"B Nardelli","year":"2001","unstructured":"Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM: Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198?204, 2001","journal-title":"Blood"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","volume":"172","author":"B He","year":"2004","unstructured":"He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A: Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL. J Immunol172:3268?3279, 2004","journal-title":"J Immunol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/ar755","volume":"5","author":"W Stohl","year":"2003","unstructured":"Stohl W: SLE-systemic lupus erythematosus: A BLySful, yet BAFFling, disorder. Arthritis Res5:136?138, 2003","journal-title":"Arthritis Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/ar299","volume":"3","author":"T Dorner","year":"2001","unstructured":"Dorner T, Putterman C: B cells, BAFF\/zTNF4, TACI, and systemic lupus erythematosus. Arthritis Res3:197?199, 2001","journal-title":"Arthritis Res"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-004-6240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-004-6240-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-004-6240-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:09:55Z","timestamp":1559275795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-004-6240-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["6240"],"URL":"https:\/\/doi.org\/10.1007\/s10875-004-6240-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}